Parkinson's disease (PD) is a progressive neurodegenerative disorder that predominantly affects the elderly population. The disease is characterized by a decrease in dopaminergic neurons in the substantia nigra pars compacta, leading to motor and non-motor symptoms.
The hallmark pathophysiological feature of PD is the degeneration of dopaminergic neurons in the substantia nigra. This leads to a decrease in the production of dopamine, a neurotransmitter responsible for regulating movement, mood, and cognition. The exact cause of this degeneration is unknown, but it is believed to involve a combination of genetic and environmental factors.
The classic motor symptoms of PD include bradykinesia, rigidity, and resting tremor. Non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction are also common and can precede motor symptoms. As the disease progresses, patients may develop postural instability leading to falls and difficulty with speech and swallowing.
Diagnosis of PD is primarily clinical, based on the presence of characteristic motor symptoms and response to dopaminergic therapy. Currently, there is no cure for PD, but medications such as levodopa and dopamine agonists can help manage symptoms. In advanced cases, deep brain stimulation may be considered.
Healthcare professionals play a crucial role in the management of PD. Early recognition and treatment can significantly improve a patient's quality of life. Furthermore, healthcare providers are instrumental in providing patient education and coordinating multidisciplinary care, including physical, occupational, and speech therapy.
Understanding the pathophysiology, clinical manifestations, and management strategies of Parkinson's disease is crucial for healthcare professionals. As the disease continues to affect an increasing number of individuals, the role of healthcare providers in diagnosing, treating, and providing ongoing support to patients with PD becomes increasingly important.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation